Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00192140 · ClinicalTrials.gov registry record · Phase 4
Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age
A Phase 4 study of Influenza, sponsored by MedImmune.
- Completed
- Registry status
- Phase 4
- Development phase
- 345
- Enrollment target
- 11
- Study locations
NCT00192140: Completed Phase 4 study of Influenza, sponsored by MedImmune.
NCT00192140 is a Phase 4 study of Influenza that has completed, run by MedImmune. The registered enrollment target is 345 participants, below the 36,802-participant average among 156 other Influenza trials with a reported enrollment target (99% lower). The trial reports 11 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00192140, a Phase 4 study of Influenza, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 345 participants
- Enrollment target
- 11
- Study locations
Study Summary
* To describe the proportion of individuals 5-49 years of age who shed vaccine strain viruses. * To describe the duration of shedding of vaccine viruses in individuals 5-49 years of age. * To describe the genotypic and phenotypic stability of shed vaccine viruses. * To describe the immune responses of FluMist in individuals 5-49 years of age. * To describe the safety of FluMist in individuals 5-49 years of age in relation to shedding and the immune response
Conditions Studied
Interventions
- BIOLOGICAL FluMist
Study Locations (11)
Florida
- SFBC International, Inc - Miami
Illinois
- Children's Memorial Hospital - Chicago
Kentucky
- Kentucky Pediatric / Adult Research, Inc - Bardstown
Maryland
- University of Maryland, School of Medicine - Baltimore
Missouri
- Center for Vaccine Development - St Louis
Nebraska
- Creighton University Medical Center - Omaha
Ohio
- Pediatric Clinical Trials International - Columbus
Pennsylvania
- Primary Physician's Research Inc. - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 345 participants |
| Start Date | 2004-06 |
| Est. Completion | 2005-01 |
| Phase | Phase 4 |
What the finished NCT00192140 record still lists
NCT00192140 is an interventional study that assigns participants to a tested intervention. The registered 345 participants enrollment target is mid-sized for trials with a published cap, below the 36,802-participant average among 156 other Influenza trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Influenza appearing as the primary indexed condition, and to 1 intervention - of which FluMist is the first listed.
NCT00192140 lists 11 locations in 11 states (Florida, Illinois, Kentucky).
Frequently Asked Questions
What is clinical trial NCT00192140 about?
NCT00192140 is a clinical study titled "Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age". * To describe the proportion of individuals 5-49 years of age who shed vaccine strain viruses. * To describe the duration of shedding of vaccine viruses in individuals 5-49 years of age. * To describe the genotypic and phenotypic stability of shed vaccine viruses. * To describe the immune responses ...
What is the current status of trial NCT00192140?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 345 participants. The study started on 2004-06. Estimated completion is 2005-01.
What conditions does trial NCT00192140 study?
This clinical trial studies the following conditions: Influenza.
What interventions are being tested in trial NCT00192140?
The interventions under investigation include: FluMist (BIOLOGICAL).
Who is sponsoring clinical trial NCT00192140?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00192140 being conducted?
This trial has 11 study locations across Florida, Illinois, Kentucky, Maryland, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00192140's enrollment target sits among peer trials
345 57th of 156 higher than 100 of 156 other Influenza trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Influenza trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults
RECRUITING · Phase 4
-
Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study
RECRUITING · Phase 4
-
Bone Marrow and Peripheral Blood Immune Responses Study
RECRUITING · Phase 4
-
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine
COMPLETED · Phase 4
-
A Study to Evaluate the Safety of HIN1 Monovalent Vaccine (MEDI3414) in Children 2 to 17 Years of Age
COMPLETED · Phase 4
-
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03972657 · 345 participants · Phase 1
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
- NCT05107674 · 345 participants · Phase 1
A Study of NX-1607 in Adults With Advanced Malignancies
- NCT05700279 · 345 participants · NA
Preventing the Development of Chronic Pain: Treating PTSD at Acute Pain Onset
- NCT05781100 · 345 participants · NA
Investigating Baby Behavior and Family Technology Use Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia